NSEAcquisition5d ago · 26 Oct 2026, 05:41 pm
Acquisition
DCM Shriram Limited · DCMSHRIRAM
✦ AI SummaryResults
DCM Shriram Limited has informed the Exchange about the outcome of its Board Meeting, where it approved unaudited financial results for the quarter and half year ended 30th September 2026, declared an interim dividend of 200% on its paid-up equity share capital, and made several other announcements including the appointment of a new nominee director, equity contribution in a joint venture, and capital expenditures.
Analysis Scores
Earnings Impact6/10
Growth Catalyst4/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
DCM Shriram Limited has informed the Exchange about Acquisition
Attachments (1)
📄pdf
Download →
DCMSHRIRAM_26102026174050_FinalOutcome26Oct2026SIGNED.pdf
View document text
DCM SHRIRAM
26th October 2026
BSE Limited National Stock Exchange of India Limited
Phiroze JeeJeeBhoy Towers, Exchange Plaza, 5th Floor, Plot No. C-1,
Dalal Street,
G Block, Bandra-Kurla Complex, Bandra (E)
Mumbai - 400 001
Mumbai - 400 051
SCRIP CODE: 523367 SCRIP CODE: DCMSHRIRAM
Sub: Outcome of Board Meeting - Unaudited Financial Results (Standalone and
Consolidated) for the Quarter/Half Year ended 30th September 2026 – other
Disclosures under Regulation 30
Dear Sirs/Madam,
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”), we inform you that the Board of Directors of the
Company, at its meeting held today, i.e., on 26th October 2026, has, inter-alia, approved:
I. Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half
year ended 30th September 2026. The copies of said Unaudited Financial Results along
with Limited Review Reports thereon of Statutory Auditors, Deloitte Haskins & Sells,
Chartered Accountants, are enclosed herewith as Annexure – I;
II. Declaration of Interim Dividend for the Financial Year 2026-27 on the paid-up equity share
capital of the Company @ 200% (₹4/- per Equity share of face value of ₹. 2/- each). As
already intimated, vide our Intimation dated 19th October 2026, the Record Date for the
purpose of the said Interim Dividend shall be Friday, 30th October 2026. Further, the
said Interim Dividend shall be paid to all eligible shareholders within 30 days from the date
of declaration of dividend.
III. Pursuant to letter received from Life Insurance Corporation of India (“LIC”) regarding
change of its nominee on the Board of the Company, and on recommendation of the
Nomination, Remuneration and Compensation Committee, the Board of Directors has
approved the appointment of Mr. Salil Vishwanath (DIN yet to be allotted) as Nominee
Director of LIC effective from 1st November 2026 or from the date of allotment of Director
Identification Number (DIN), whichever is later, in place of Mr. Rabinarayan Mishra
(DIN:10377015), subject to approval of the shareholders of the Company.
Accordingly, Mr. Rabinarayan Mishra will cease to be director of the Company effective
from 1st November 2026. There is no other material reason for cessation of
Mr. Rabinarayan Mishra as Nominee Director on the Board of the Company.
Further, Mr. Salil Vishwanath is not debarred from holding the office of Director pursuant
to any Order of SEBI, MCA or any such authority.
DCM SHRIRAM LTD.
Corporate Office: 2nd Floor (West Wing), Worldmark 1, Aerocity, New Delhi -110037, India Tel: +91 11 42100200
Registered Office: Plot No. 82, Sector 32, Institutional Area, Gurugram - 122 001, Haryana, India Tel: +91 124 4513700
e-mail: response@dcmshriram.comwebsite:www.dcmshriram.com
GIN: L74899HR1989PLC137147
Shriram Fertilisers & Chemicals • Shriram Alkali & Chemicals • DCM Shriram Sugar • Bioseed • Fenesta Building Systems • Shriram Cement
DCM SHRIRAM
Details as required under the Listing Regulations read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 are given in
Annex- II.
IV. Equity contribution of upto ₹50 crores in Shriram Teknor Limited (STL), a Joint Venture
between the Company and Teknor Apex B.V., towards its capital investment of upto
₹133 crores for setting up new manufacturing lines for the manufacture of speciality PVC
grades, speciality medical grades and diversification into the manufacture of Halogen-
Free Flame Retardant (HFFR) grades. Capital investment is proposed to be met through
equity contribution of ₹50 crores by each of the JV partners of STL and the balance
amount would be met by STL through internal cash generation and debt funding.
Details as required under the Listing Regulations read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026 are given in
Annex- III.
V. Capital expenditure of upto ₹60 crores towards installation of the Filter Presses at Cement
Plant in Kota with a view to mitigating losses in the Cement Plant and providing greater
operational flexibility in handling sludge.
VI. Capital expenditure of upto ₹145 crores towards installation of Solar Power Plant at Kota
complex of the Company to meet the power requirement of its Vinyl Plant. This will enable
the Company to meet its power requirement of upto 8 MW in cost effective manner, which
is being presently met through grid power, where the cost per unit is high as compared to
solar power.
VII. Purchase of one additional electrolyser each for Kota and Bharuch Caustic plants at
capital expenditure of upto ₹120 crores to debottleneck these plants.
The Board meeting commenced at 2:15 P.M and concluded at 4:15 P.M.
Kindly take the above information on record.
The same is available on the Company’s website i.e., https://www.dcmshriram.com/.
Thanking you,
Yours faithfully,
For DCM Shriram Limited
(Deepak Gupta)
Company Secretary & Compliance Officer
Encl.: a/a
DCM SHRIRAM LTD.
Corporate Office: 2nd Floor (West Wing), Worldmark 1, Aerocity, New Delhi -110037, India Tel: +91 11 42100200
Registered Office: Plot No. 82, Sector 32, Institutional Area, Gurugram - 122 001, Haryana, India Tel: +91 124 4513700
e-mail: response@dcmshriram.comwebsite:www.dcmshriram.com
GIN: L74899HR1989PLC137147
Shriram Fertilisers & Chemicals • Shriram Alkali & Chemicals • DCM Shriram Sugar • Bioseed • Fenesta Building Systems • Shriram Cement
Chartered Accountants
Deloitte
7th Floor, Building 10, Tower B,
DLF Cyber City Complex,
Haskins & Sells DLF City Phase II,
Gurugram - 122 002
Haryana, India
Phone: +91 124 679 2000
Fax: +91 124 679 2012
INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE FINANCIAL RESULTS
TO THE BOARD OF DIRECTORS OF DCM SHRIRAM LIMITED
1. We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of DCM SHRIRAM
LIMITED {the "Company"), for the quarter and half year ended September 30, 2026 {the "Statement"), being
submitted by the Company pursuant to the requirement of Regulation 33 and Regulation 52 of the SEBI {Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended {the "LODR Regulations").
2. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of
Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian
Accounting Standard 34 "Interim Financial Reporting" {"Ind AS 34"), prescribed under Section 133 of the Companies
Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and
in compliance with Regulation 33 and Regulation 52 of the LODR Regulations. Our responsibility is to express a
conclusion on the Statement based on our review.
3. We conducted our review of the Statement in accordance with the Standard on Review Engagements {SRE) 2410
'Reviewoflnterim Financial Information Performed by the Independent Auditor of the Entity', issued by the Institute
of Chartered Accountants of India {ICAI}. A review of interim financial information consists of making inquiries,
primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and
other review procedures. A review is substantially less in scope than an audit conducted in accordance with
Standards on Auditing specified under section 143(10} of the Companies Act, 2013 and consequently does not enable
us to obtain assurance that we would become aware of all significant matters that might be identified in an audit.
Accordingly, we do not express an audit opinion.
4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to
believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles
laid down in the aforesaid Indian Accounting Standard and other accounting prin
[Showing first 8,000 characters — download PDF for full document]